QLT Inc.

Quick facts

Marketed products

• verteporfin PDT · Ophthalmology
  Verteporfin is a photosensitizing agent that accumulates in abnormal blood vessels and is activated by light to generate reactive oxygen species that destroy those vessels.

Phase 3 pipeline

• Visudyne for injection · Ophthalmology
  Visudyne (verteporfin) is a photosensitizing agent that accumulates in abnormal blood vessels and is activated by light to produce reactive oxygen species that destroy those vessels.

Phase 2 pipeline

• QLT091001

Phase 1 pipeline

• QLT0074

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• QLT Inc. portfolio CI brief
• QLT Inc. pipeline updates RSS